TACTELVO Trademark

Trademark Overview


On Tuesday, November 6, 2018, a trademark application was filed for TACTELVO with the United States Patent and Trademark Office. The USPTO has given the TACTELVO trademark a serial number of 79248061. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, October 21, 2022. This trademark is owned by NOVARTIS AG. The TACTELVO trademark is filed in the Pharmaceutical Products category with the following description:

[ Anti-infectives; ] anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; [ pharmaceutical preparations acting on the central nervous system; ] pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations fo...
tactelvo

General Information


Serial Number79248061
Word MarkTACTELVO
Filing DateTuesday, November 6, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, October 21, 2022
Registration Number5816161
Registration DateTuesday, July 30, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements


Certificate of Correction for RegistrationIn the statement, class 5 has been corrected per the Restriction dated 10/3/19, and per the fnote dated 10/17/19.
Goods and Services[ Anti-infectives; ] anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; [ pharmaceutical preparations acting on the central nervous system; ] pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; ] pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma * ; except in the fields of oncology, infectious diseases and diseases of the central nervous system *
Certificate of Correction for RegistrationIn the Statement, class 5 has been corrected per the Restriction dated October 3, 2019, and per the fnote dated May 27, 2022.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, October 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, January 19, 2023LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, November 6, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, November 6, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, June 3, 2022LIMITATION FROM THE IB EXAMINED AND ENTERED
Sunday, May 29, 2022CORRECTION UNDER SECTION 7 ¿ PROCESSED
Monday, July 6, 2020INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, June 18, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, October 19, 2019LIMITATION FROM THE IB EXAMINED AND ENTERED
Friday, October 18, 2019CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, October 4, 2019NOTIFICATION PROCESSED BY IB
Friday, October 4, 2019LIMITATION OF GOODS RECEIVED FROM IB
Friday, September 27, 2019LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, September 17, 2019FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 17, 2019FINAL DISPOSITION PROCESSED
Thursday, August 29, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Sunday, June 23, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, February 27, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Friday, February 8, 2019NOTIFICATION PROCESSED BY IB
Wednesday, January 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 23, 2019NOTICE OF PUBLICATION
Tuesday, January 8, 2019APPLICATION FILING RECEIPT MAILED
Saturday, January 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Wednesday, January 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 28, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 27, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB